Vascular cross-sectional area in rat mammary tumours; influence of noradrenaline

Anticancer Research

Volumn 16, Issue 3 A, 1996, Pages 1161-1164

  Kopf I ^a   Hultborn, R ^a,b   Weiss, L ^a   Carlsson, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Experimental tumours; Noradrenaline; Vascularity

Indexed keywords

FLUORESCENT DYE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION;

ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; CARBOCYANINES; CRYOULTRAMICROTOMY; FEMALE; FLUORESCENT DYES; HEART RATE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; NOREPINEPHRINE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; VASOCONSTRICTOR AGENTS;

EID: 0029980264     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658. 1988.
2. Chaplin DJ, Olive PL and Durand RE: Intermittent Blood Flow in a Murine Tumor: Radiobiological Effects. Cancer Res 47: 597-601, 1987.
3. Huggins CB: Experimental Leukemia and Mammary Cancer Chicago. University of Chicago Press, 1979.
4. Tveit E. Hultborn R and Weiss L: Effects of noradrenaline on interstitial fluid pressure in induced rat mammary tumours. Cancer Lett 27: 249-253.1985.
5. Weiss L. Tveit E and Hultborn R: Vascular resistance characteristics of 7.12-dimethylbenz(a)anthracene-induced rat mammary tumors and normal tissues as studied in Vitro Cancer Res 45: 2478-2480, 1985.